HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/6/H3144    most recent 00327.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Hashim, S. Articles by Anand-Srivastava, M. B. Search for Related Content PubMed PubMed Citation Articles by Hashim, S. Articles by Anand-Srivastava, M. B.

Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through G_i protein/MAP kinase/PI3-kinase/AKT pathways

Department of Physiology and Groupe de recherche sur le système nerveux autonome, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada

Submitted 29 March 2006 ; accepted in final form 10 August 2006

The present studies were undertaken to investigate the effect of C-atrial natriuretic peptide (ANP)_4–23 and several peptide fragments containing 12 amino acids from different regions of the cytoplasmic domain of natriuretic peptide receptor (NPR)-C on cell proliferation in the absence or presence of angiotensin (ANG) II, endothelin (ET)-1, and arginine vasopressin (AVP) in A-10 vascular smooth muscle cells (VSMC). The peptide fragments used have either complete G_i activator sequences K⁴⁶¹-H⁴⁷² (peptide 1) and H⁴⁸¹-H⁴⁹² (peptide 3) or partial G_i activator sequences R⁴⁶⁹-K⁴⁸⁰ (peptide 2) and I⁴⁶⁵-H⁴⁷² (peptide Y) with truncated COOH or NH₂ terminus, respectively. The other peptide used had no structural specificity (Q⁴⁷³-K⁴⁸⁰, peptide X) or was the scrambled peptide control for peptide 1 (peptide Z). ANG II, ET-1 and AVP significantly stimulated DNA synthesis in these cells as determined by [³H]thymidine incorporation that was inhibited by peptides 1, 2, and 3 and not by peptides X, Y, and Z in a concentration-dependent manner, with an apparent K_i between 1 and 10 nM. In addition, C-ANP_4–23, which interacts with NPR-C, also inhibited DNA synthesis stimulated by vasoactive peptides; however, the inhibition elicited by C-ANP_4–23 was not additive with the inhibition elicited by peptide 1. On the other hand, basal DNA synthesis in these cells was not inhibited by C-ANP_4–23 or the peptide fragments. Furthermore, vasoactive peptide-induced stimulation of DNA synthesis was inhibited by PD-98059 and wortmannin, and this inhibition was potentiated by peptide 1. In addition, peptide 1 also inhibited vasoactive peptide-induced phosphorylation of ERK1/2 and AKT and enhanced expression of G_i proteins. These data suggest that C-ANP_4–23 and small peptide fragments containing 12 amino acids irrespective of the region of the cytoplasmic domain of NPR-C inhibit proliferative responses of vasoactive peptides through G_i protein and MAP kinase/phosphatidylinositol 3-kinase/AKT pathways.

vasoactive peptides; DNA synthesis; extracellular signal-regulated kinase 1/2; peptide 1; vascular smooth muscle cell

This article has been cited by other articles:

				M. Bassil, Y. Li, and M. B. Anand-Srivastava Peroxynitrite inhibits the expression of Gi{alpha} protein and adenylyl cyclase signaling in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H775 - H784. [Abstract] [Full Text] [PDF]

				R. A. Rose and W. R. Giles Natriuretic peptide C receptor signalling in the heart and vasculature J. Physiol., January 15, 2008; 586(2): 353 - 366. [Abstract] [Full Text] [PDF]